Pharma Journalist 8947 posts 0 comments

Novartis announced Kisqali (ribociclib) achieved statistically significant improvement in overall survival in the Phase III MONALEESA-3 clinical trial. This is the second Phase III…
Read More...

Alligator Bioscience announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013…
Read More...

Exelixis, Inc. announced that it has entered into an exclusive collaboration, option and license agreement with Aurigene Discovery Technologies Limited (Aurigene), the India-based…
Read More...

SMi Reports: SMi has released an exclusive interview with industry expert Dr Sigbjorn Gregusson, Managing Director, BioBank AS ahead of the upcoming Biobanking conference this September…
Read More...

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited announced that Alvotech and…
Read More...

Nephron Pharmaceuticals Corporation and Rapid Micro Biosystems announced the Nephron 503(b) Outsourcing division will deliver critical medical supplies to hospitals faster than ever,…
Read More...

Eli Lilly and Company announced that Verzenio (abemaciclib) demonstrated a statistically significant improvement in overall survival in the Phase 3 MONARCH 2 clinical trial. These…
Read More...

Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of…
Read More...

Lyndra Therapeutics, the company making daily pills a thing of the past, announced it has received a $13 million grant from the Bill & Melinda Gates Foundation for the development…
Read More...

Sunovion Pharmaceuticals Inc. (Sunovion) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for dasotraline, a novel dopamine and…
Read More...